Skip to content
The Intraday Markets
Pulse

Briefings

Morning BriefOvernight tape and the setup for the openMid-Morning UpdateWhat changed after the opening bell

Markets

Market DashboardTape, movers, watchlist, and cross-asset contextPre-Market SheetOvernight setup, futures, and early moversGlobal SessionsInternational clocks and index performanceInsider ActivityLatest reported executive transactions

EHC Research

Price ChartTechnical charting and drawing workspaceFundamentals ChartCompare financial metrics across timeCompany OverviewA visual snapshot of company performanceFinancial StatementsPrice, filings, key statistics, and news

Newsletter

Morning Production ReportRanked stories, charts, and newsletter readiness

Financial Statements

Explore

Markets, briefings, and company research

EHC
Pulse

Briefings

MorningMid-Morning

Markets

DashboardPre-MarketGlobalInsiders

EHC Research

ChartFundamentalsOverviewFinancials

Newsletter

Morning Report

Newsletter operations and account tools are available from your profile menu after sign-in.

EHC

$123.59
+$0.04 (0.03%)+0.03%
Closed
Loading chart...
IndexN/A
Market Cap12.26B
Enterprise Value13.28B
Income$0.15B
Sales$1.46B
EmployeesN/A
P/E21.16
P/S1.80
P/B4.37
P/C24.29
EV/EBITDA9.46
EV/SalesN/A
EPS (ttm)5.84
EarningsN/A
Gross Margin95.71%
Oper. Margin17.74%
Profit Margin9.54%
Volume0.50M
Shs Outstand0.10B
Change0.03%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
Income Statement by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Revenue$5.37B$4.80B$4.35B$4.01B$3.57B$4.61B$4.28B$3.91B
Cost of Revenue$3.14B$2.82B$2.60B$2.31B$171.00M$167.90M$158.70M$149.30M
Gross Profit$2.23B$1.98B$1.75B$1.70B$3.40B$4.44B$4.12B$3.76B
Gross Margin41.56%41.30%40.32%42.43%95.21%96.35%96.29%96.19%
Operating Expenses$1.37B$258.00M$1.12B$1.04B$3.40B$3.74B$3.44B$3.12B
Operating Income$864.50M$1.72B$630.20M$659.40M$0.00$692.50M$681.60M$649.40M
Operating Margin16.09%35.92%14.49%16.42%0.00%15.04%15.94%16.59%
Net Income$455.70M$352.00M$271.00M$412.20M$284.20M$358.70M$292.30M$271.10M
Net Margin8.48%7.33%6.23%10.27%7.97%7.79%6.83%6.93%
EPS (Basic)$4.53$3.54$2.72$4.15$2.87$3.65$2.99$2.73
EBITDAN/AN/AN/AN/AN/AN/AN/AN/A
Stock Option Compensation ExpenseN/AN/AN/AN/AN/AN/AN/AN/A
Price To Earnings RatioN/AN/AN/AN/AN/AN/AN/AN/A
Price To Sales RatioN/AN/AN/AN/AN/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/AN/AN/AN/AN/A
Market CapitalizationN/AN/AN/AN/AN/AN/AN/AN/A
Balance Sheet by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Cash & Short Term InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Short Term ReceivablesN/AN/AN/AN/AN/AN/AN/AN/A
InventoriesN/AN/AN/AN/AN/AN/AN/AN/A
Other Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Net Property, Plant & EquipmentN/AN/AN/AN/AN/AN/AN/AN/A
Total Investments and AdvancesN/AN/AN/AN/AN/AN/AN/AN/A
Long-Term Note ReceivableN/AN/AN/AN/AN/AN/AN/AN/A
Intangible AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Other AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Assets$6.53B$6.10B$5.64B$6.86B$6.45B$6.08B$5.23B$4.89B
Short Term Debt Incl. Current Port. of LT DebtN/AN/AN/AN/AN/AN/AN/AN/A
Accounts PayableN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax PayableN/AN/AN/AN/AN/AN/AN/AN/A
Other Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Provision for Risks ChargesN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Other LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$3.69B$3.81B$3.77B$4.47B$4.44B$4.15B$3.36B$3.25B
Non-Equity ReservesN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Stock - Carrying ValueN/AN/AN/AN/AN/AN/AN/AN/A
Common EquityN/AN/AN/AN/AN/AN/AN/AN/A
Total Shareholders Equity$2.07B$1.65B$1.31B$1.91B$1.59B$1.35B$1.33B$1.18B
Accumulated Minority InterestN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$2.07B$1.65B$1.31B$1.91B$1.59B$1.35B$1.33B$1.18B
Total Liabilities & Stockholders Equity$6.53B$6.10B$5.64B$6.86B$6.45B$6.08B$5.23B$4.89B
Book Value Per ShareN/AN/AN/AN/AN/AN/AN/AN/A
Tangible Book Value Per ShareN/AN/AN/AN/AN/AN/AN/AN/A
Full-Time EmployeesN/AN/AN/AN/AN/AN/AN/AN/A
Price to Book RatioN/AN/AN/AN/AN/AN/AN/AN/A
Return on AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Return on EquityN/AN/AN/AN/AN/AN/AN/AN/A
Return on Invested CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Quick RatioN/AN/AN/AN/AN/AN/AN/AN/A
Current RatioN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Net Income$455.70M$352.00M$271.00M$412.20M$284.20M$358.70M$292.30M$271.10M
DepreciationN/AN/AN/AN/AN/AN/AN/AN/A
Other Funds (Non Cash)N/AN/AN/AN/AN/AN/AN/AN/A
Funds from OperationsN/AN/AN/AN/AN/AN/AN/AN/A
Extraordinary ItemN/AN/AN/AN/AN/AN/AN/AN/A
Changes in Working CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Income Taxes PayableN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Operating Activities$1.00B$850.80M$705.80M$715.80M$704.70M$635.30M$762.40M$657.20M
Capital ExpendituresN/AN/AN/AN/AN/AN/AN/AN/A
Net Assets From AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Fixed Assets and BusinessesN/AN/AN/AN/AN/AN/AN/AN/A
Purchase or Sale of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Purchase of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Sale Or Maturity of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Other UsesN/AN/AN/AN/AN/AN/AN/AN/A
Other SourcesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Investing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Cash Dividends PaidN/AN/AN/AN/AN/AN/AN/AN/A
Change in Capital StockN/AN/AN/AN/AN/AN/AN/AN/A
Repurchase of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Proceeds from Stock OptionsN/AN/AN/AN/AN/AN/AN/AN/A
Issuance or Reduction of Debt, NetN/AN/AN/AN/AN/AN/AN/AN/A
Change in Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Issuance of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Reduction of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Net Financing Active Other Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Other Financing Activities UsesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Financing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Exchange Rate EffectN/AN/AN/AN/AN/AN/AN/AN/A
Net Change in CashN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Dividends (Cash Flow)N/AN/AN/AN/AN/AN/AN/AN/A
Price to Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A

Company coverage

Latest news

20 stories
Jun 15 · 5:36PMHealthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitInvesting.com ↗May 7 · 12:43PMEncompass Health declares dividend on common stockBenzinga ↗Apr 7 · 9:39PMINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Encompass Health Corporation – EHCGlobeNewswire Inc. ↗Mar 24 · 8:52PMINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLTGlobeNewswire Inc. ↗Mar 10 · 1:00PMEncompass Health Corporation Investigated by the Portnoy Law FirmGlobeNewswire Inc. ↗Feb 19 · 1:44PMEncompass Health declares dividend on common stockBenzinga ↗Oct 28 · 1:50AMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Oct 23 · 1:48PMEncompass Health declares dividend on common stockBenzinga ↗
Show 12 more stories↓
Oct 21 · 10:49PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Oct 12 · 9:07PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Oct 9 · 6:54PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Oct 1 · 6:59PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Sep 28 · 5:50PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Sep 25 · 9:39PMENCOMPASS (EHC) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the FirmGlobeNewswire Inc. ↗Sep 22 · 8:46PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Sep 9 · 10:27PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Sep 8 · 5:52PMJohnson Fistel Investigates Encompass Health Following Reports of Poor Patient Outcomes at Rehab FacilitiesGlobeNewswire Inc. ↗Sep 5 · 6:37PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Sep 2 · 11:26PMEHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc. ↗Sep 1 · 6:52PMROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation – EHCGlobeNewswire Inc. ↗

Insider Trading

View All
Insider
Type
Shares
Price
Value
Date
Darby John Patrick
Sell
8.9K
$125.95
$1.1M
Aug 10, 26
Tarr Mark J
Sell
171.6K
$125.46
$21.5M
Aug 10, 26
COLTHARP DOUGLAS E
Sell
18.9K
$125.38
$2.4M
Aug 10, 26
Douglas Coltharp
Sell
18.9K
$125.38
$2.4M
Aug 10, 26
John Patrick Darby
Sell
8.9K
$125.95
$1.1M
Aug 10, 26

Company

CEO: Mark J. TarrEmployees: 42300www.encompasshealth.com
About the company↓

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Discover more

You may be interested in
MA

Mastercard Inc

$569.29

↑ 0.40%
NFLX

Netflix Inc

$78.16

↑ 0.11%
GOOGL

Alphabet Inc

$345.90

↑ 0.30%
AMZN

Amazon.com Inc

$262.65

↓ 0.75%
MSFT

Microsoft Corp

$495.40

↓ 0.33%
JPM

JPMorgan Chase & Co

$362.84

↓ 0.14%
CRM

Salesforce Inc

$196.21

↓ 2.56%
ABX

Abacus Global Management Inc

$9.27

↑ 8.80%
META

Meta Platforms Inc

$589.85

↓ 0.79%
TSLA

Tesla Inc

$342.27

↑ 0.49%
ADBE

Adobe Inc

$264.02

↓ 2.40%
IBM

IBM Corp

$234.32

↓ 1.01%
The Intraday Markets

© 2026 The Intraday. All rights reserved.

Market data may be delayedFor informational purposes onlyFMP · Massive · SEC